Heart Disease News and Research

Latest Heart Disease News and Research

MicroStockProfit.com: CUR reports net loss of $5,096,983 for third-quarter of 2009

MicroStockProfit.com announces an investment report featuring Neuralstem Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

21 Apr 2010

A*STAR's BMRC and SIgN award grants for twelve research projects on infectious diseases and immunology

Twelve research projects on infectious diseases and immunology have been awarded grants by A*STAR's Biomedical Research Council (BMRC) and Singapore Immunology Network (SIgN) this year.

21 Apr 2010

"Destination therapy" for end-stage heart failure patients

Federal approval for an alternative therapy to heart transplantation led to a new lease on life for a UT Southwestern Medical Center patient who suffered from heart failure for nearly a decade.

21 Apr 2010

Researchers screen Afro-Caribbean students to predict risk of heart disease

Researchers at the University of Hertfordshire are screening an Afro-Caribbean cohort of students this week to gauge their predisposition to heart disease in later life.

21 Apr 2010

Gene test predicts statins' effectiveness in reducing risk of colorectal cancer

A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Center finds.

21 Apr 2010

New sensor wristband monitors various body functions

A small blood lab that fits into the pocket of a jacket can quickly analyze the risk of blood clots in legs prior to a long distance flight; a sensor wristband for measuring electric smog can warn pacemaker patients of life-threatening exposure: "Smart plastics" can turn such tools into reality.

21 Apr 2010

Nutrition experts call for sodium reduction strategies

Responding to the health threat posed by Americans' over-consumption of sodium, experts in the department of nutrition at Harvard School of Public Health (HSPH) and The Culinary Institute of America (CIA) called today for sodium reduction strategies that are strong and effective-and that maximize the enjoyment people derive from food.

21 Apr 2010

Systems biologists integrate new genetic framework to help predict adverse drug reactions

In a major step toward predicting adverse drug reactions, systems biologists at Mount Sinai School of Medicine in New York City have integrated genetic, cellular and clinical information to find out why certain medicines can trigger fatal heart arrhythmias.

21 Apr 2010

Proteus Biomedical's wireless personal health device receives FDA marketing clearance

Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that it has received 510(k) clearance from the US Food and Drug Administration to market its wireless personal health device, the Raisin Personal Monitor.

21 Apr 2010

miRNAs may generate new insights on cancer and possible future treatments

Scientists are methodically unlocking the biological processes that lead to cancer, and recent discoveries with microRNAs (miRNAs) are revolutionizing their understanding and leading to clinical trials of potentially effective treatments.

21 Apr 2010

Inpatient mortality rates not the best way to judge hospital care

Inpatient mortality rates, used by organizations to issue "report cards" on the quality of individual U.S. hospitals, are a poor gauge of how well hospitals actually perform and should be abandoned in favor of measures that more accurately assess patient harms and the care being provided, argue patient safety experts in a paper out today.

21 Apr 2010

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China reported that its asthma drug Laevo-Bambutero will receive the China's State Food & Drug Administration's (SFDA) Fast Track Approval to enter clinical trials. The SFDA's Drug Review and Evaluation Center told the Company during recent consultations at the end of the Company's IND that formal approval would be granted by the Beijing office of the SFDA.

21 Apr 2010

New study quantifies prevalence of MRSA infections in different patient populations

A multi-center study led by a researcher at Rhode Island Hospital has determined that long-term elder care, HIV-infected and hemodialysis patients are at increased risk of carrying methicillin-resistant Staphylococcus aureus (MRSA) in their nose.

21 Apr 2010

Higher consumption of added sugars in processed foods associated with lower levels of HDL-C: Study

Consuming a higher amount of added sugars in processed or prepared foods is associated with lower levels of high-density lipoprotein cholesterol and higher levels of triglycerides, which are important risk factors for cardiovascular disease, according to a study in the April 21 issue of JAMA.

21 Apr 2010

CSI establishes $25M credit facility with Silicon Valley Bank

Cardiovascular Systems, Inc., announced today that it has established a $25 million credit facility with Silicon Valley Bank and up to $4 million in convertible debt with Partners for Growth. Proceeds will be used to consolidate existing outstanding debt, provide working capital for growth and for general corporate purposes.

21 Apr 2010

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

Duke University Medical Center and Laboratory Corporation of America Holdings announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the translation of newly discovered biomarkers into widely available clinical tools that can measure individual therapeutic responses, predict disease progression, and evaluate any number of biologic or disease-causing processes.

21 Apr 2010

More testimony on Patel trial

In the ongoing trial of Dr. Jayant Patel for manslaughter of three men and grievous injury to the fourth during his tenure as Director of surgery at Bundaberg base hospital new testimony has surfaced. Patel had pleaded not guilty.

21 Apr 2010

3M Littmann Model 3200 and Zargis Cardioscan software receive red dot design award

3M and Zargis Medical Corp., today announced that the 3M Littmann Electronic Stethoscope Model 3200 and the Zargis Cardioscan software recently received two industry awards for design and innovation: the "red dot: best of the best" award for product design, given by the Design Zentrum Nordrhein Westfalen, an internationally known design institution located in Essen, Germany, and the Medical Design Excellence Award, sponsored by Medical Device & Diagnostic Industry magazine.

21 Apr 2010

Added sugars in diet related to high cholesterol and increased risk of heart disease, say researchers

According to researchers, an average American gets 16% of calories from the sugar in their diet. These may be sugars added to processed foods during manufacture.

21 Apr 2010

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Abraxis BioScience, Inc., a fully integrated biotechnology company, announced study results today that demonstrate a regimen of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with bevacizumab (Avastin®) may have potential in the treatment of triple-negative breast cancers.

21 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

MicroStockProfit.com: CUR reports net loss of $5,096,983 for third-quarter of 2009

A*STAR's BMRC and SIgN award grants for twelve research projects on infectious diseases and immunology

"Destination therapy" for end-stage heart failure patients

Researchers screen Afro-Caribbean students to predict risk of heart disease

Gene test predicts statins' effectiveness in reducing risk of colorectal cancer

New sensor wristband monitors various body functions

Nutrition experts call for sodium reduction strategies

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Proteus Biomedical's wireless personal health device receives FDA marketing clearance

miRNAs may generate new insights on cancer and possible future treatments

Inpatient mortality rates not the best way to judge hospital care

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

New study quantifies prevalence of MRSA infections in different patient populations

Higher consumption of added sugars in processed foods associated with lower levels of HDL-C: Study

CSI establishes $25M credit facility with Silicon Valley Bank

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

More testimony on Patel trial

3M Littmann Model 3200 and Zargis Cardioscan software receive red dot design award

Added sugars in diet related to high cholesterol and increased risk of heart disease, say researchers

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in